Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 14 studies | 39% ± 21% | |
CD16-positive, CD56-dim natural killer cell, human | 10 studies | 24% ± 5% | |
natural killer cell | 9 studies | 23% ± 7% | |
plasmablast | 9 studies | 46% ± 24% | |
CD16-negative, CD56-bright natural killer cell, human | 6 studies | 25% ± 4% | |
IgG plasma cell | 5 studies | 28% ± 13% | |
B cell | 4 studies | 17% ± 2% | |
mature NK T cell | 4 studies | 25% ± 3% | |
IgA plasma cell | 4 studies | 30% ± 13% | |
CD8-positive, alpha-beta T cell | 4 studies | 21% ± 8% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 24% ± 7% | |
gamma-delta T cell | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of ZBP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 361.01 | 577 / 578 | 80% | 3.20 | 926 / 1155 |
stomach | 69% | 100.44 | 249 / 359 | 87% | 3.44 | 249 / 286 |
intestine | 60% | 241.50 | 580 / 966 | 82% | 3.30 | 430 / 527 |
breast | 58% | 68.74 | 268 / 459 | 61% | 2.82 | 679 / 1118 |
esophagus | 41% | 38.13 | 598 / 1445 | 67% | 2.70 | 123 / 183 |
bladder | 52% | 78.95 | 11 / 21 | 56% | 2.72 | 282 / 504 |
peripheral blood | 100% | 1484.04 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 1689.51 | 241 / 241 | 0% | 0 | 0 / 0 |
uterus | 29% | 19.07 | 50 / 170 | 63% | 3.22 | 291 / 459 |
thymus | 62% | 120.52 | 404 / 653 | 31% | 1.13 | 187 / 605 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.17 | 25 / 29 |
kidney | 49% | 98.36 | 44 / 89 | 36% | 0.89 | 328 / 901 |
tonsil | 0% | 0 | 0 / 0 | 84% | 4.65 | 38 / 45 |
pancreas | 4% | 3.49 | 13 / 328 | 76% | 3.25 | 136 / 178 |
prostate | 64% | 70.40 | 158 / 245 | 15% | 0.36 | 77 / 502 |
ovary | 11% | 6.67 | 19 / 180 | 68% | 3.03 | 294 / 430 |
adipose | 72% | 81.67 | 871 / 1204 | 0% | 0 | 0 / 0 |
liver | 50% | 42.42 | 113 / 226 | 17% | 0.47 | 68 / 406 |
skin | 8% | 4.76 | 136 / 1809 | 49% | 2.12 | 232 / 472 |
brain | 10% | 10.53 | 274 / 2642 | 14% | 0.45 | 98 / 705 |
blood vessel | 24% | 31.78 | 314 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 17% | 12.72 | 43 / 258 | 3% | 0.07 | 8 / 230 |
heart | 10% | 7.06 | 90 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.22 | 6 / 80 |
muscle | 1% | 1.22 | 12 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050832 | Biological process | defense response to fungus |
GO_0060340 | Biological process | positive regulation of type I interferon-mediated signaling pathway |
GO_2000659 | Biological process | regulation of interleukin-1-mediated signaling pathway |
GO_0060545 | Biological process | positive regulation of necroptotic process |
GO_0051607 | Biological process | defense response to virus |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0002218 | Biological process | activation of innate immune response |
GO_0006915 | Biological process | apoptotic process |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003726 | Molecular function | double-stranded RNA adenosine deaminase activity |
GO_0003723 | Molecular function | RNA binding |
GO_0003692 | Molecular function | left-handed Z-DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | ZBP1 |
Protein name | Z-DNA-binding protein 1 (DNA-dependent activator of IFN-regulatory factors) (DAI) (Tumor stroma and activated macrophage protein DLM-1) Z-DNA binding protein 1 |
Synonyms | DLM1 C20orf183 |
Description | FUNCTION: Key innate sensor that recognizes and binds Z-RNA structures, which are produced by a number of viruses, such as herpesvirus, orthomyxovirus or flavivirus, and triggers different forms of cell death . ZBP1 acts as an essential mediator of pyroptosis, necroptosis and apoptosis (PANoptosis), an integral part of host defense against pathogens, by activating RIPK3, caspase-8 (CASP8), and the NLRP3 inflammasome (By similarity). Key activator of necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, via its ability to bind Z-RNA: once activated upon Z-RNA-binding, ZBP1 interacts and stimulates RIPK3 kinase, which phosphorylates and activates MLKL, triggering execution of programmed necrosis (By similarity). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: ZBP1 recognizes and binds Z-RNA structures that are produced in infected nuclei by orthomyxoviruses, such as the influenza A virus (IAV), leading to ZBP1 activation, RIPK3 stimulation and subsequent MLKL phosphorylation, triggering disruption of the nuclear envelope and leakage of cellular DNA into the cytosol . ZBP1-dependent cell death in response to IAV infection promotes interleukin-1 alpha (IL1A) induction in an NLRP3-inflammasome-independent manner: IL1A expression is required for the optimal interleukin-1 beta (IL1B) production, and together, these cytokines promote infiltration of inflammatory neutrophils to the lung, leading to the formation of neutrophil extracellular traps (By similarity). In addition to its direct role in driving necroptosis via its ability to sense Z-RNAs, also involved in PANoptosis triggered in response to bacterial infection: component of the AIM2 PANoptosome complex, a multiprotein complex that triggers PANoptosis (By similarity). Also acts as the apical sensor of fungal infection responsible for activating PANoptosis (By similarity). Involved in CASP8-mediated cell death via its interaction with RIPK1 but independently of its ability to sense Z-RNAs (By similarity). In some cell types, also able to restrict viral replication by promoting cell death-independent responses (By similarity). In response to Zika virus infection in neurons, promotes a cell death-independent pathway that restricts viral replication: together with RIPK3, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (By similarity). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (By similarity). .; FUNCTION: (Microbial infection) In case of herpes simplex virus 1/HHV-1 infection, forms hetero-amyloid structures with HHV-1 protein RIR1/ICP6 which may inhibit ZBP1-mediated necroptosis, thereby preventing host cell death pathway and allowing viral evasion. . |
Accessions | H0Y6D1 ENST00000453793.1 A2RRL9 ENST00000371173.8 [Q9H171-1] ENST00000541799.1 [Q9H171-6] ENST00000395822.7 [Q9H171-7] Q9H171 |